News, trends, and stories from the synthetic biology industry

Hi all,
 

Cultured meat, produced from bioreactors instead of animal slaughter, has been approved for sale by a regulatory authority for the first time. The development has been hailed as a landmark moment across the meat industry, according to The Guardian. Eat Just’s ‘chicken bites’ will be initially available in a Singapore restaurant.

 

Thank you to Codexis for sponsoring this week's newsletter, and my good friend John Nicols, the CEO. Codexis is a leading protein engineering company developing proteins for the commercial manufacture of pharmaceuticals and fine chemicals, industrial enzymes, enzymes for use in molecular biology, diagnostics and other life science applications, and biotherapeutics. If you would like to sponsor a newsletter, then please get in touch.

 

In funding news, Twist Bioscience has raised $323.7 million and Codexis is raising $70.2 million in a public offering of common stock.

 

In other news: Last week, SynBioBeta hosted our first conference dedicated solely to how biotech companies can tell the story of their brands and build lasting relationships with consumers. Read the biggest conference takeaways in my latest article for Forbes.

The Stunning Pace Of Progress: One Year In, Covid-19 Treatments And Vaccines Are Close At Hand (INFOGRAPHIC) The global race to deliver proven antibody treatments and vaccines for COVID-19 is well underway. A slew of candidates — including many made possible by advances in synthetic biology — are in late-stage clinical trials.

Have a great week,

Regards 
John

Latest News

BioBuilder Founder and Executive Director, Natalie Kuldell, featured as 2020 MWM Trailblazer Award Winner (Press release)

Codex DNA releases new synthetic genomes for the fight against COVID-19 (Press release)

How will AlphaFold change bioscience research? (The Biologist)

Sherlock Biosciences announces discovery of novel CRISPR-Cas enzymes, enabling simple multiplex diagnostic solutions (Press release)

Are we still friends? What Brexit means for UK synthetic biology (Labiotech.eu)

Open-source toolkit helps developing countries meet demand for COVID-19 research and diagnostics (Cambridge University)

The biggest open opportunity in synthetic biology (a16z)

Sherlock Biosciences strengthens intellectual property portfolio in CRISPR-based diagnostics through exclusive license agreement with Tolo Biotech (Press release)

New CRISPR-based test for COVID-19 uses a smartphone camera (Gladstone Institutes)

Ocean Spray and Amai Proteins partner to create the first protein-sweetened reduced sugar cranberry juice (Press release)

XPRIZE launches a four-year-long competition to improve alt-meat (The Spoon)

China is reportedly developing ‘biologically enhanced’ soldiers. So is the U.S. (Future Human)

Who's hiring?

Biologist: Cambridge Consultants – Boston

 

Johns Hopkins Center for Health Security: Research Associate/Analyst – Baltimore, Maryland

 

Senior Scientist – Analytical Biochemistry: Inscripta – Pleasanton, California

 

University of California: Associate Teaching Professor of Bioengineering – Santa Cruz, California

 

Application Scientist: Codex DNA – San Diego, California

Scientist, Metabolic Engineer: Conagen – Bedford, MA

 

Scientist, Fungal Biology: Conagen – Bedford, MA

 

Scientist, Synthetic Biologist: Novome Biotechnologies – South San Francisco, CA

 

Biomolecular Nanomaterials Scientist: Berkeley Lab – Bay Area, CA

 

Graphic Designer: SynBioBeta (contractor)

 

Senior Scientist, Biochemistry: Inscripta – Pleasanton, CA

 

 

Feature your job here